PDB ID 1GAG     CHAIN A
Protein name INSULIN RECEPTOR, TYROSINE KINASE DOMAIN
Uniprot Accession P06213
The number of similar proteins 22
The number of binding states 4
The number of binding partners 4

Coloring

Unicolor (beige)

The number of binding partners

Group

Binding
state
Binding partners
1GAG (CHAIN: A)
1 Monomeric state
2 Q14449  
3 Q9Z200   Q9Z200  
4 P06213   P18031  

Downdload

Format:

Molecule viewer


Only interaction residues
#binding
partners
  2
  1
  0

Sequence information

1   VFPSSVFVPD   EWEVSREKIT   LLRELGQGSF   GMVYEGNARD   IIKGEAETRV   50
51   AVKTVNESAS   LRERIEFLNE   ASVMKGFTCH   HVVRLLGVVS   KGQPTLVVME   100
101   LMAHGDLKSY   LRSLRPEAEN   NPGRPPPTLQ   EMIQMAAEIA   DGMAYLNAKK   150
151   FVHRDLAARN   CMVAHDFTVK   IGDFGMTRDI   XETDXXRKGG   KGLLPVRWMA   200
201   PESLKDGVFT   TSSDMWSFGV   VLWEITSLAE   QPYQGLSNEQ   VLKFVMDGGY   250
251   LDQPDNCPER   VTDLMRMCWQ   FNPKMRPTFL   EIVNLLKDDL   HPSFPEVSFF   300
301   HSEENK           350

Variants

Residue AA Source /
dbSNP
Clinical
Significance
Allele
Frequency
(> 0.0001)
AlphaMissense
pathogenicity
Disease name
985_VAL MET VAR_004091
rs1799816
LB/B - 0.1825 -
985_VAL MET gnomAD
chr19:7125518
rs1799816
- 0.00841464 0.1825 -
985_VAL MET 8.3kJPN
chr19:7125518
rs1799816
- 0.0001 0.1825 -
988_GLU ALA 8.3kJPN
chr19:7125508
-
- 0.0001 0.3865 -
993_ARG GLN VAR_004092
rs121913148
LP/P - 0.9257 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
993_ARG GLN ClinVar
chr19:7125493
rs121913148
Likely pathogenic - 0.9257 Insulin-resistant diabetes mellitus AND acanthosis nigricans|Rabson-Mendenhall syndrome [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297|MONDO:MONDO:0009874,MedGen:C0271695,OMIM:262190,Orphanet:769]; Leprechaunism syndrome [MONDO:MONDO:0009517,MedGen:C0265344,OMIM:246200,Orphanet:508]; Hyperinsulinism due to INSR deficiency [MONDO:MONDO:0012381,MedGen:C1864952,OMIM:609968,Orphanet:263458]; Insulin-resistant diabetes mellitus AND acanthosis nigricans [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
996_ILE PHE VAR_015922
-
LB/B - 0.9192 -
1000_ARG TER ClinVar
chr19:7125473
rs121913144
Pathogenic - - Rabson-Mendenhall syndrome|Insulin-resistant diabetes mellitus AND acanthosis nigricans [MONDO:MONDO:0009874,MedGen:C0271695,OMIM:262190,Orphanet:769|MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
1000_ARG TER 8.3kJPN
chr19:7125473
rs121913144
- 0.0001 - -
1008_GLY VAL VAR_004093
rs121913135
LP/P - 0.9996 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1008_GLY VAL ClinVar
chr19:7125448
rs121913135
Pathogenic - 0.9996 Insulin-resistant diabetes mellitus AND acanthosis nigricans [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
1012_GLU ASP 8.3kJPN
chr15:99478141
-
- 0.0001 0.8709 -
1021_ASP HIS 8.3kJPN
chr15:99478166
-
- 0.0001 - -
1021_GLY ASP 8.3kJPN
chr19:7125409
rs200921389
- 0.0068 0.1517 -
1026_ARG HIS 8.3kJPN
chr19:7125394
rs748109926
- 0.0001 0.0848 -
1027_VAL MET VAR_079549
rs1135401741
US - 0.9792 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1028_ALA VAL VAR_015923
rs1599874183
LP/P - 0.9948 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1028_ALA VAL ClinVar
chr19:7125388
rs1599874183
Likely pathogenic - 0.9948 not provided [MedGen:C3661900]
1038_LEU VAL VAR_041432
rs56395521
LB/B - 0.1535 -
1038_LEU VAL gnomAD
chr19:7125359
rs56395521
- 0.000282673 0.1535 -
1039_ARG GLN 8.3kJPN
chr19:7125355
rs372010924
- 0.0002 0.2932 -
1041_ARG GLN 8.3kJPN
chr19:7125349
rs367827848
- 0.0001 0.5446 -
1048_ALA ASP VAR_004094
-
LP/P - 0.9996 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1051_MET ILE ClinVar
chr15:99478258
rs1596468719
Likely pathogenic - 0.9995 Growth delay due to insulin-like growth factor I resistance [MONDO:MONDO:0010038,MedGen:C1849157,OMIM:270450,Orphanet:73273]
1051_MET ILE ClinVar
chr19:7125318
rs2144813778
Likely pathogenic - 0.9995 not provided [MedGen:C3661900]
1055_ASN SER 8.3kJPN
chr15:99478269
rs780382569
- 0.0005 - -
1061_ARG TER ClinVar
chr15:99478548
-
Pathogenic - - not provided [MedGen:CN517202]
1068_LYS GLU VAR_015924
rs909008899
LB/B - 0.2927 -
1089_ARG CYS 8.3kJPN
chr19:7122913
rs749951195
- 0.0001 0.9868 -
1092_ARG TRP VAR_015925
rs1229730671
LP/P - 0.9877 Leprechaunism (LEPRCH) [MIM:246200]
1101_ARG HIS 8.3kJPN
chr19:7122771
rs202160383
- 0.0001 0.0949 -
1109_MET ILE gnomAD
chr19:7122746
rs776740574
- 0.000353916 0.4371 -
1110_ILE VAL 8.3kJPN
chr15:99482469
-
- 0.0001 0.0958 -
1113_ALA VAL 8.3kJPN
chr19:7122735
rs772334614
- 0.0001 0.4239 -
1116_ILE THR VAR_015926
-
LP/P - 0.9769 Rabson-Mendenhall syndrome (RMS) [MIM:262190]
1124_ASN THR 8.3kJPN
chr15:99482512
-
- 0.0001 0.2284 -
1131_ARG GLN VAR_015927
-
LP/P - 0.9981 Type 2 diabetes mellitus (T2D) [MIM:125853]
1131_ARG TRP VAR_015928
rs111993466
LP/P - 0.9995 Rabson-Mendenhall syndrome (RMS) [MIM:262190]
1134_ALA THR VAR_004095
rs121913139
LP/P - 0.9994 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1134_ALA THR ClinVar
chr19:7122673
rs121913139
Pathogenic - 0.9994 Insulin resistance|Insulin-resistant diabetes mellitus AND acanthosis nigricans [Human Phenotype Ontology:HP:0000855,MedGen:C0021655|MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
1135_ALA GLU VAR_004096
rs121913154
LP/P - 0.9997 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1135_ALA GLU ClinVar
chr19:7122669
rs121913154
Pathogenic - 0.9997 Insulin-resistant diabetes mellitus AND acanthosis nigricans [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
1149_GLY ARG ClinVar
chr15:99482586
rs1596472892
Pathogenic/Likely pathogenic - 0.9997 Growth delay due to insulin-like growth factor I resistance|not provided [MONDO:MONDO:0010038,MedGen:C1849157,OMIM:270450,Orphanet:73273|MedGen:CN517202]
1152_GLY ASP ClinVar
chr15:99486158
rs1596476061
Likely pathogenic - 0.9999 NK-cell enteropathy [MONDO:MONDO:0016996,MedGen:C4509932,Orphanet:263665]
1153_MET ILE VAR_004097
rs121913157
LB/B - 0.9994 -
1164_ARG GLN VAR_004098
rs121913150
LP/P - 0.9669 Type 2 diabetes mellitus (T2D) [MIM:125853]
1164_ARG GLN ClinVar
chr19:7120718
rs121913150
Pathogenic - 0.9669 Type 2 diabetes mellitus [Human Phenotype Ontology:HP:0005965,Human Phenotype Ontology:HP:0005978,Human Phenotype Ontology:HP:0100652,MONDO:MONDO:0005148,MeSH:D003924,MedGen:C0011860,OMIM:125853]
1174_ARG GLN VAR_015929
rs121913156
LP/P - 0.9993 Hyperinsulinemic hypoglycemia, familial, 5 (HHF5) [MIM:609968]
1174_ARG TRP VAR_015930
rs1568426700
LP/P - 0.9996 Leprechaunism (LEPRCH) [MIM:246200]
1174_ARG GLN ClinVar
chr19:7120688
rs121913156
Pathogenic - 0.9993 Insulin-resistant diabetes mellitus AND acanthosis nigricans|Hyperinsulinism due to INSR deficiency|not provided [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297|MONDO:MONDO:0012381,MedGen:C1864952,OMIM:609968,Orphanet:263458|MedGen:CN517202]
1174_ARG TRP ClinVar
chr19:7120689
rs1568426700
Pathogenic - 0.9996 Insulin resistance [Human Phenotype Ontology:HP:0000855,MedGen:C0021655]
1177_SER TYR ClinVar
chr15:99486233
rs1596476163
Likely pathogenic - - Growth delay due to insulin-like growth factor I resistance [MONDO:MONDO:0010038,MedGen:C1849157,OMIM:270450,Orphanet:73273]
1178_PRO LEU VAR_004099
rs1295645322
LP/P - 0.996 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1179_GLU ASP VAR_015931
-
LP/P - 0.9946 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1179_GLU LYS VAR_015932
-
LP/P - 0.9978 Leprechaunism (LEPRCH) [MIM:246200]
1190_SER TRP ClinVar
chr15:99486272
-
Likely pathogenic - 0.9997 not provided [MedGen:C3661900]
1193_TRP LEU VAR_004100
rs52800171
LP/P - 0.9964 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1194_SER ALA 8.3kJPN
chr19:7119593
rs201979105
- 0.0004 0.7726 -
1200_TRP SER VAR_004101
rs121913140
LP/P - 0.9956 Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549]
1200_TRP SER ClinVar
chr19:7119574
rs121913140
Pathogenic - 0.9956 Insulin-resistant diabetes mellitus AND acanthosis nigricans [MONDO:MONDO:0012520,MedGen:C0342278,OMIM:610549,Orphanet:2297]
1203_THR SER 8.3kJPN
chr19:7119565
-
- 0.0001 0.1144 -
1224_GLU TER ClinVar
chr15:99491894
-
Likely pathogenic - - not provided [MedGen:CN517202]
1226_GLY SER 8.3kJPN
chr15:99491900
rs368518102
- 0.0003 0.3664 -
1227_TYR ASP 8.3kJPN
chr19:7119494
-
- 0.0004 0.4318 -
1231_PRO THR 8.3kJPN
chr15:99491915
rs751193576
- 0.0001 0.6347 -
1243_ARG HIS 8.3kJPN
chr19:7117407
rs746000108
- 0.0004 0.0725 -
1255_THR ALA VAR_041433
rs55875349
LB/B - 0.0797 -
1267_MET VAL 8.3kJPN
chr15:99500375
-
- 0.0001 - -
1280_GLU LYS gnomAD
chr15:99500414
rs45526336
- 0.000103407 0.0895 -
1280_GLU LYS 8.3kJPN
chr15:99500414
rs45526336
- 0.0001 0.0895 -
(Powered by wupsivus)

Reference

PiSite: a database of protein interaction sites using multiple binding states in the PDB, Miho Higurashi, Takashi Ishida and Kengo Kinoshita, Nucleic Acids Research 2009 37(Database issue):D360-D364

COPYRIGHTc2008-2019 Miho Higurashi, Takashi Ishida and Kengo Kinoshita. All rights reserved.